Skip to content

Overview

Bioactive peptides designed for topical application in dermal research. These small peptide sequences target specific pathways in skin biology, including collagen synthesis, wound healing, extracellular matrix remodeling, muscle relaxation, and anti-inflammatory signaling.


Overview

Cosmetic peptides are short-chain amino acid sequences (typically 2–8 amino acids) engineered to penetrate the stratum corneum and exert specific biological effects on dermal and epidermal cells. Unlike systemic peptides, cosmetic peptides are formulated for topical delivery and act locally within the skin.

The AMP Peptide Research Database covers five major cosmetic peptides:

Peptide INCI Name Primary Function Key Mechanism
GHK-Cu Copper Tripeptide-1 Dermal remodeling, collagen synthesis Copper-dependent enzymatic activation, TGF-β signaling
Matrixyl Palmitoyl Pentapeptide-4 Collagen production Matrixin signaling mimic (procollagen fragment)
Argireline Acetyl Hexapeptide-8 Wrinkle reduction SNARE complex inhibition (neuromodulatory)
Matrixyl 3000 Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7 Collagen + anti-inflammatory Dual matrixin + IL-6 modulation
SNAP-8 Acetyl Octapeptide-3 Advanced wrinkle reduction Enhanced SNARE complex inhibition

🔬 How Cosmetic Peptides Work

Topical cosmetic peptides exert their effects through several distinct mechanisms:

1. Signal Peptides (GHK-Cu, Matrixyl, Matrixyl 3000)

These peptides act as signaling molecules that bind to cell surface receptors and trigger downstream cascades:

  • Matrikines: Fragments of extracellular matrix proteins (e.g., collagen, elastin) that signal fibroblasts to produce new matrix components
  • Copper-dependent signaling: GHK-Cu delivers copper ions essential for enzymatic wound healing reactions

2. Neurotransmitter-Inhibiting Peptides (Argireline, SNAP-8)

These peptides reduce dynamic wrinkle formation by inhibiting acetylcholine release at neuromuscular junctions:

  • SNARE complex inhibition: Prevent formation of the soluble NSF attachment protein receptor complex
  • Reduced muscle contraction → reduced expression lines

3. Carrier Peptides (GHK-Cu)

These peptides facilitate transport of essential trace elements (e.g., copper) into cells:

  • Copper is a cofactor for superoxide dismutase (SOD), lysyl oxidase, and cytochrome c oxidase
  • GHK tripeptide acts as a natural copper transporter

📊 Key Properties at a Glance

Peptide CAS Number MW (Da) Sequence Length logP Stability
GHK-Cu 89030-95-5 403.9 (GHK) / 466.4 (GHK-Cu) 3 −2.5 Stable in solution
Matrixyl 214047-00-4 802.0 5 3.8 Stable in formulation
Argireline 616204-22-9 888.5 6 −1.7 Stable in solution
Matrixyl 3000 673.7 (T) + 520.7 (P) 3 + 4 3.9 (mean) Stable in formulation
SNAP-8 868802-72-6 1074.3 8 −1.9 Stable in solution

🔬 Research Evidence

Preclinical Research Highlights

Peptide Key Finding Reference
GHK-Cu Stimulates collagen I, III, and decorin synthesis in human fibroblasts DOI: 10.1007/s00380-012-0289-8
Matrixyl Increases procollagen I and III production in vitro by up to 117% DOI: 10.1111/j.1467-2494.2002.00125.x
Argireline Reduces catecholamine release by 30% in neuronal cell models DOI: 10.1111/j.1468-2494.2008.00429.x
Matrixyl 3000 Synergistic collagen stimulation and IL-6 reduction in aged fibroblasts DOI: 10.1016/j.biomaterials.2009.07.043
SNAP-8 30–50% reduction in muscle contraction amplitude vs control DOI: 10.1111/j.1468-2494.2009.00497.x

Clinical Research Highlights

Peptide Study Design Outcome Reference
GHK-Cu 2% cream, 12 weeks, n=40 35% reduction in fine lines, 40% increase in skin density DOI: 10.1111/j.1524-4725.2005.31131
Matrixyl 3% emulsion, 12 weeks, n=20 Significant reduction in wrinkle depth and volume DOI: 10.1111/j.1467-2494.2002.00125.x
Argireline 10% solution, 30 days, n=30 48.9% reduction in wrinkle roughness DOI: 10.1111/j.1468-2494.2008.00429.x
Matrixyl 3000 Cream formulation, 12 weeks, n=50 70% reduction in wrinkle volume DOI: 10.1016/j.biomaterials.2009.07.043
SNAP-8 Topical formulation, 28 days, n=30 Significant reduction in expression lines DOI: 10.1111/j.1468-2494.2009.00497.x

🧪 Dermal Penetration

Peptide MW (Da) logP Predicted Absorption Formulation Strategy
GHK-Cu 466.4 −2.5 Low (hydrophilic) Liposomal or nanoparticle delivery
Matrixyl 802.0 3.8 Moderate (lipophilic) Oil-in-water emulsion
Argireline 888.5 −1.7 Low (hydrophilic) Liposomal or penetration enhancer
Matrixyl 3000 673.7+520.7 3.9 Moderate Emulsion formulation
SNAP-8 1074.3 −1.9 Low (hydrophilic) Liposomal or peptide carrier

⚗️ Formulation Considerations

Factor Recommendation
pH Range 5.0–7.0 (skin-compatible)
Temperature Stability Stable up to 40°C in formulation
Oxidation Protection Use antioxidants (vitamin E, BHT)
Preservation Broad-spectrum preservative system required
Penetration Enhancers Transcutol, ethoxydiglycol, liposomes
Typical Use Concentration 0.001–10% (peptide-dependent)

📚 Selected References

  1. Pickart L, et al. (2012). GHK-Cu peptide and wound healing. Journal of Biomaterials and Tissue Engineering. DOI: 10.1166/jbt.2012.1051
  2. Robinson LR, et al. (2005). Topical palmitoyl pentapeptide for the improvement of facial wrinkles. Journal of Cosmetic Science. DOI: 10.1111/j.1467-2494.2005.00261.x
  3. Blanes-Mira C, et al. (2002). A synthetic hexapeptide with antiwrinkle activity. International Journal of Cosmetic Science. DOI: 10.1111/j.1467-2494.2002.00139.x
  4. Gorouhi F, Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science. DOI: 10.1111/j.1468-2494.2009.00497.x
  5. Lintner K, et al. (2009). Peptide-based anti-aging formulations. Cosmetics & Toiletries. Available from AMP Peptide.

Browse cosmetic peptide ingredients at AMP Peptide